Shaman inverts its drug development model

Noteworthy

Shaman inverts its drug development model

With its long-term capital security in mind, Shaman Pharmaceuticals Inc. has decided to focus on the pharmaceutical industry as its primary customer and will concentrate its development efforts in diseases best modeled by whole animal testing.

Although the South San Francisco company last week said it will

Read the full 554 word article

How to gain access

Continue reading with a
two-week free trial.